These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38272563)

  • 21. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.
    Yoon JY; Jiang W; Orr CR; Rushton C; Gargano S; Song SJ; Modi M; Hozack B; Abraham J; Mallick AB; Brooks JSJ; Rosenbaum JN; Zhang PJ
    Cancer Genet; 2021 Nov; 258-259():74-79. PubMed ID: 34583232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma.
    Ramachandran I; Lowther DE; Dryer-Minnerly R; Wang R; Fayngerts S; Nunez D; Betts G; Bath N; Tipping AJ; Melchiori L; Navenot JM; Glod J; Mackall CL; D'Angelo SP; Araujo DM; Chow WA; Demetri GD; Druta M; Van Tine BA; Grupp SA; Abdul Razak AR; Wilky B; Iyengar M; Trivedi T; Winkle EV; Chagin K; Amado R; Binder GK; Basu S
    J Immunother Cancer; 2019 Oct; 7(1):276. PubMed ID: 31651363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chordoma: the entity.
    Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
    Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival.
    Abdulrahman Z; Santegoets SJ; Sturm G; Charoentong P; Ijsselsteijn ME; Somarakis A; Höllt T; Finotello F; Trajanoski Z; van Egmond SL; Mustafa DAM; Welters MJP; de Miranda NFCC; van der Burg SH
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35217577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
    Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
    Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Mankin H; Duan Z
    Spine (Phila Pa 1976); 2010 Aug; 35(18):1668-75. PubMed ID: 20386502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cancer stem-like cells in chordoma.
    Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
    J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
    Zuccato JA; Patil V; Mansouri S; Liu JC; Nassiri F; Mamatjan Y; Chakravarthy A; Karimi S; Almeida JP; Bernat AL; Hasen M; Singh O; Khan S; Kislinger T; Sinha N; Froelich S; Adle-Biassette H; Aldape KD; De Carvalho DD; Zadeh G
    Neuro Oncol; 2022 Mar; 24(3):442-454. PubMed ID: 34614192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.
    Secrier M; McGrath L; Ng F; Gulati S; Raymond A; Nuttall BRB; Berthe J; Jones EV; Sidders BS; Galon J; Barrett JC; Angell HK
    Cancer Res Commun; 2023 Oct; 3(10):2133-2145. PubMed ID: 37819239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.
    Hruban RH; Traganos F; Reuter VE; Huvos AG
    Am J Pathol; 1990 Aug; 137(2):435-47. PubMed ID: 1696786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.